Chemoradiation for cervical cancer

Journal of Pelvic Surgery

Volumn 6, Issue 3, 2000, Pages 123-125

  DeBemardo, Robert ^a   Trimble, Edward L ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004835538     PISSN: 10772847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage 1IB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group study. J Clin Oncol 17:13-39, 1999.
2. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:11-37. 1999.
3. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144. 1999.
4. Keys HM, Bundy B, Stchman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154, 1999.
5. Peters WA, Liu PY, Barrett R, et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early stage carcinoma ot the cervix after radical hysterectomy and pelvic lymphadenectomy J Clin Oncol (in press).